RA Capital Management, LLC, 10% Owner at Dicerna Pharmaceuticals Inc (DRNA), bought 2,428,571 shares at $15.00 ($15.0M) on 2014-02-04, disclosed to the SEC on 2014-02-05.
Open-market purchase of $15.0M DRNA by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 1,428,571 | $0 | 0.0% |
| 2 | $15.00 | 1,000,000 | $15.0M | 100.0% |
| Total | $6.18 avg | 2,428,571 | $15.0M | 100% |
| Filing → |
| KALA | BUY | 2018-10-05 | $40.0M | — | Filing → |
| ARVN | BUY | 2018-10-03 | $16.0M | — | Filing → |
| WVE | BUY | 2017-11-15 | $9.9M | — | Filing → |